Statins have been shown to induce p21 (also termed CDKN1A) that plays an important role in cell cycle inhibition [8,9] to antagonize RAS-dependent signaling pathways [10,11] or to downregulate BCL-2 expression in cancer cell lines and, thus, affect apoptosis [12]. This evidence concerns the gene CDKN1A and cancer.